Objective-To determine patterns of use of dilatation and curettage in Britain as compared with those in the United States; to examine variations in utilisation rates within one regional health authority.
Introduction
Women who are referred to gynaecological clinics for complaints of menstrual problems commonly undergo dilatation and curettage.' The operation involves a general anaesthetic and often a two day stay,2 although the Audit Commission has estimated that up to 86% of patients could be treated as day cases. ' Originally the procedure was thought to have a therapeutic effect on dysfunctional uterine bleeding, but studies have failed to support this. 4 The procedure is performed for diagnostic purposes, primarily to exclude endometrial malignancy, but its efficacy as a diagnostic tool has been questioned. 112 Early critics of dilatation and curettage for women presenting with dysfunctional menstrual bleeding argued that it should be restricted to women aged over 35 or 40 on the grounds that serious pathology-in particular endometrial cancer-is uncommon in younger women.' 25 More recently it has been suggested that dilatation and curettage should be replaced by altemative methods of endometrial sampling, with or without hysteroscopy, which seem to be equally accurate and do not require inpatient admission and general anaesthesia. '6-29 Studies evalu- ating newer methods of outpatient endometrial biopsy have generally reported high levels of patient acceptability, although some women experience pain and discomfort when undergoing these procedures. Dilatation and curettage carries a risk of complications including uterine perforation and laceration of the cervix. '13 Rates of dilatation and curettage apparently fell by one third in the United States between 1979 and 1984.'°W e were interested to see whether gynaecological practice in Britain has changed in response to these critiques of dilatation and curettage and to compare rates ofuse of the procedure in Britain with those in the United States. To this end we examined national trends and conducted a detailed analysis of routine statistics on hospital admissions within the Oxford Regional Health Authority.
Methods
Dilatation and curettage is currently thought to be valuable for evacuating retained products of conception, so for this analysis we excluded pregnancy related procedures from all data sources.
Once a patient has had a hysterectomy she is no longer a potential candidate for dilatation and curettage. In order to see whether the international dif per 10000 in 1989. 36 The more likely explanation is that the increase in prospective payment schemes in the United States, which has put downward pressure on rates of use of elective inpatient surgery, has led them to favour the cheaper option of an outpatient procedure.
Interestingly, hysterectomy rates have also declined, although this operation is still performed at one and a half times the British rate. Clearly a woman who has had her uterus removed is no longer at risk of dilatation and curettage. In England the lifetime risk of hysterectomy is around 20%,37 which means that true rates for dilatation and curettage among populations of women at risk would be roughly 25% (that is, 1/(1-0 2)) higher than published population based rates. This is the rate which one would like to compare, and normally such adjustments are immaterial, but for dilatation and curettage and hysterectomy they could be crucial. The true adjustment depends, of course, on the relation of the age specific rates for the two operations. In the United States the lifetime risk, which is clearly a function of past hysterectomy rates as shown in figure 2, has changed with time. It was estimated to be around 29% in 1970 and 43% by 1985. 38 Thus the early part of the rates from dilatation and curettage in the United States in figure 1 are too low by around 4l1% and the latter part by around 75%. Hence the eightfold reduction in rates in the United States can only partly be explained by this twofold adjustment for the true population at risk.
SIMILAR INDICATIONS FOR TWO PROCEDURES
Rates of use of these two operations are linked in another way since they are performed for similar indications, often on the same patients. Routine dilatation and curettage before hysterectomy used to be common in the United States but this is no longer considered necessary.5 Rates of use of most elective operations are much higher in the United States than in Britain,39 so it is particularly surprising to find that dilatation and curettage is performed more than six times more frequently in British hospitals. It is, however, possible that the observed decline in dilatation and curettage rates in American hospitals represents simply a change of setting from acute hospitals to independent ambulatory centres, which are not necessarily contributing data to the official statistics, but where day case dilatation and ciirettage may be being performed. Despite extensive inquiries we were unable to ascertain the extent to which dilatation and curettage, as opposed to the newer endometrial sampling techniques, was being carried out in ambulatory settings.
The differences between district health authorities in rates of use of dilatation and curettage were also dramatic. Variations within one region of Britain may be influenced by variations in levels of resources to a small extent, but they are more likely to be the result of variations in clinical judgment.40 General practitioners are known to differ in their propensity to refer patients to specialist outpatient clinics, and it is possible that some of the variation in dilatation and curettage rates observed here could be due to differing pattems of demand for specialist services.4' However, it is also obvious from these results that gynaecologists' styles of clinical practice differ. Anecdotal evidence suggests that specialists disagree on the desirability of using outpatient endometrial sampling procedures. It is clear that many continue to believe that it is appropriate to perform dilatation and curettage on younger women, despite the weight of published evidence arguing that this cannot be justified. It is also clear from our results that rates of use of day case surgery are very different between the districts. However, this example illustrates an important problem with the management emphasis on promoting day case surgery. Consultants with low use of day case dilatation and curettage who are instead using outpatient procedures rather than admitting patients will receive no credit for this good practice so long as management information systems exclude clinical data on outpatient activity.
The reasons for British gynaecologists' apparent reluctance to change, as compared with their American counterparts, are hard to establish. Possible explanations could include lack of financial incentives, lack of training in the new techniques, shortage of equipment, lack of suitable facilities, or unwillingness among patients to undergo outpatient procedures. It is also possible that British gynaecologists are unconvinced by the research evidence on the efficacy and acceptability of the new procedures. Certainly there is a dearth of scientifically sound randomised controlled trials which could settle areas of doubt and there is a strong case for more research in this area. However, in our view the explanation for the continuing high use of dilatation and curettage in Britain probably has more to do with the way in which outpatient clinics are currently organised, making it easier to place a patient on the waiting list for admission than to initiate diagnostic procedures in the clinic.
Based on the prices for inpatient and day case procedures quoted to general practitioner fundholders in each of the districts (an admittedly crude measure), we estimate that the dilatation and curettage operations carried out in the Oxford region cost around £2m at 1992 prices. A considerable part of this sum could be saved by reducing the number of investigations performed on younger women and resorting to outpatient procedures for most of the remainder. Since the rate of use of inpatient dilatation and curettage in the Oxford region is already lower than the national average, savings for the NHS as a whole could be considerable. Comparisons between inpatient curettage and outpatient procedures in the United States have calculated a 10-fold reduction in costs.'942 Since it would seem that this saving could be achieved at no harm and possibly considerable benefit to patients, we recommend that gynaecology departments should consider current dilatation and curettage practice a priority for clinical audit. It will be interesting to see whether pressure from purchasers in Britain will have the same effect on dilatation and curettage utilisation rates as it has in the United States. Since current pattems of use lack scientific justification in terms of efficacy or efficiency, there would seem to be plenty of scope for rationalisation.
